SG Americas Securities LLC boosted its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 45.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,476 shares of the medical technology company’s stock after buying an additional 12,700 shares during the period. SG Americas Securities LLC owned approximately 0.06% of Hill-Rom Holdings worth $3,222,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Independent Portfolio Consultants Inc. increased its stake in shares of Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock worth $107,000 after buying an additional 849 shares during the last quarter. Meadow Creek Investment Management LLC increased its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock worth $120,000 after buying an additional 64 shares during the last quarter. Neuburgh Advisers LLC increased its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock worth $165,000 after buying an additional 88 shares during the last quarter. Tyers Asset Management LLC increased its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock worth $210,000 after buying an additional 112 shares during the last quarter. Finally, Bancorpsouth Inc. purchased a new stake in shares of Hill-Rom Holdings during the first quarter worth about $210,000. Hedge funds and other institutional investors own 84.27% of the company’s stock.

Shares of Hill-Rom Holdings, Inc. (HRC) opened at 73.09 on Monday. Hill-Rom Holdings, Inc. has a 1-year low of $50.50 and a 1-year high of $84.65. The firm has a market capitalization of $4.82 billion, a P/E ratio of 42.59 and a beta of 1.22. The stock has a 50 day moving average of $78.68 and a 200-day moving average of $73.28.

Hill-Rom Holdings (NYSE:HRC) last issued its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a return on equity of 1.90% and a net margin of 0.83%. Hill-Rom Holdings’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.81 earnings per share. On average, equities analysts expect that Hill-Rom Holdings, Inc. will post $3.82 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is currently 41.62%.

ILLEGAL ACTIVITY WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/08/21/sg-americas-securities-llc-has-3-22-million-stake-in-hill-rom-holdings-inc-hrc.html.

A number of equities research analysts have issued reports on the stock. Cantor Fitzgerald set a $86.00 price objective on shares of Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. BidaskClub downgraded shares of Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Morgan Stanley raised their price target on shares of Hill-Rom Holdings from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, June 30th. Finally, Needham & Company LLC reduced their price target on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $88.17.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the completion of the sale, the senior vice president now owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.20% of the stock is owned by corporate insiders.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.